Literature DB >> 22009615

Chronic kidney disease epidemic: myth and reality.

Filippo Mangione1, Antonio Dal Canton.   

Abstract

In recent years, an epidemic of chronic kidney disease (CKD) has emerged as one of the major public health problem. The prevalence of CKD is largely sustained by the inclusion of a substantial proportion of the elderly population within stage 3 CKD, according to the Kidney Disease Outcomes Quality Initiative staging system. However, some clarifications are necessary when interpreting these data. In fact, renal function "normally" declines with age, without bearing any unfavourable outcome; in addition, the Modification of Diet in Renal Disease formula used to calculate glomerular filtration rate (GFR) underestimates kidney function in the elderly and in women. Considerable interest in CKD has been generated by the evidence that predialysis CKD is associated with the increased risk of cardiovascular disease (CVD). Again, potential confounding factors must be ruled out. Age is thought to play a major role in this context. The most common causes of CKD, hypertension and diabetes mellitus, are also known to affect cardiovascular outcomes directly, thus preventing the recognition of an independent effect of kidney dysfunction on mortality by CVD. Taken together, these considerations point for a better definition of CKD. Early identification of patients at risk for accelerated decline in renal function is mandatory to plan strategies for screening and preventing CKD and its complications. At present, detection of CKD in the general population requires a multi-dimensional approach that should include the evaluation of clinical risk conditions, evaluation of albuminuria and sequential monitoring of GFR.

Entities:  

Mesh:

Year:  2011        PMID: 22009615     DOI: 10.1007/s11739-011-0686-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  38 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males.

Authors:  D F DAVIES; N W SHOCK
Journal:  J Clin Invest       Date:  1950-05       Impact factor: 14.808

3.  Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Authors:  Carmen A Peralta; Michael G Shlipak; Suzanne Judd; Mary Cushman; William McClellan; Neil A Zakai; Monika M Safford; Xiao Zhang; Paul Muntner; David Warnock
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

5.  Low glomerular filtration in the population: prevalence, associated disorders, and awareness.

Authors:  M Cirillo; M Laurenzi; M Mancini; A Zanchetti; C Lombardi; N G De Santo
Journal:  Kidney Int       Date:  2006-07-05       Impact factor: 10.612

6.  A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.

Authors:  Thomas J Hoerger; John S Wittenborn; Joel E Segel; Nilka R Burrows; Kumiko Imai; Paul Eggers; Meda E Pavkov; Regina Jordan; Susan M Hailpern; Anton C Schoolwerth; Desmond E Williams
Journal:  Am J Kidney Dis       Date:  2010-02-08       Impact factor: 8.860

Review 7.  The burden of kidney disease: improving global outcomes.

Authors:  Garabed Eknoyan; Norbert Lameire; Rashad Barsoum; Kai-Uwe Eckardt; Adeera Levin; Nathan Levin; Francesco Locatelli; Alison MacLeod; Raymond Vanholder; Rowan Walker; Haiyan Wang
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

8.  Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study.

Authors:  J F M Wetzels; L A L M Kiemeney; D W Swinkels; H L Willems; M den Heijer
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

9.  Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.

Authors:  Roberto Minutolo; Luca De Nicola; Giampiero Mazzaglia; Maurizio Postorino; Claudio Cricelli; Lorenzo G Mantovani; Giuseppe Conte; Bruno Cianciaruso
Journal:  Am J Kidney Dis       Date:  2008-05-12       Impact factor: 8.860

10.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

View more
  5 in total

1.  Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease.

Authors:  Yalcin Solak; Mahmut Ilker Yilmaz; Alper Sonmez; Mutlu Saglam; Erdinc Cakir; Hilmi Umut Unal; Mahmut Gok; Kayser Caglar; Yusuf Oguz; Mujdat Yenicesu; Murat Karaman; Seyit Ahmet Ay; Abduzhappar Gaipov; Suleyman Turk; Abdulgaffar Vural; Juan J Carrero
Journal:  Clin Exp Nephrol       Date:  2012-11-20       Impact factor: 2.801

Review 2.  Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update.

Authors:  Alessandro Di Cerbo; Federica Pezzuto; Lucia Palmieri; Valentina Rottigni; Tommaso Iannitti; Beniamino Palmieri
Journal:  Int Urol Nephrol       Date:  2013-04-13       Impact factor: 2.370

3.  In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy.

Authors:  Fabio Fabbian; Massimo Gallerani; Marco Pala; Alfredo De Giorgi; Raffaella Salmi; Fabio Manfredini; Francesco Portaluppi; Francesco Dentali; Walter Ageno; Dimitri P Mikhailidis; Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2012-12-18       Impact factor: 3.397

Review 4.  Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits.

Authors:  Giuliano Tocci; Barbara Citoni; Vivianne Presta; Giovanna Leoncini; Francesca Viazzi; Barbara Bonino; Massimo Volpe; Roberto Pontremoli
Journal:  Intern Emerg Med       Date:  2019-12-21       Impact factor: 3.397

Review 5.  Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE: A Systematic Review.

Authors:  Anirudh Rao; Katharina Brück; Shona Methven; Rebecca Evans; Vianda S Stel; Kitty J Jager; Lotty Hooft; Yoav Ben-Shlomo; Fergus Caskey
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.